Frazier Life Sciences Public Fund, L.P. - 01 Nov 2025 SCHEDULE 13D/A Report for KALVISTA PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (KALV)

Filing Manager
Frazier Life Sciences Public Fund, L.P.
Reporting Manager
Frazier Life Sciences Public Fund, L.P.
Security
KALVISTA PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share
Symbol
KALV
Shares outstanding
50,239,435 shares
Disclosed Ownership
3,466,521 shares
Ownership
6.9%
Form type
SCHEDULE 13D/A
Filing time
04 Nov 2025, 17:21:59 UTC
Date of event
01 Nov 2025
Previous filing
20 Aug 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Frazier Life Sciences Public Fund, L.P. disclosed 6.9% ownership in KALVISTA PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (KALV) on 01 Nov 2025."

Quick Takeaways

  • Frazier Life Sciences Public Fund, L.P. filed SCHEDULE 13D/A for KALVISTA PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (KALV).
  • Disclosed ownership: 6.9%.
  • Date of event: 01 Nov 2025.

What Changed

  • Previous schedule filing date: 20 Aug 2025.
  • Current filing was accepted on 04 Nov 2025, 17:21.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (11)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Frazier Life Sciences Public Fund, L.P. 6.9% 3,466,521 0 3,466,521 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P. 0001863769
FHMLSP, L.P. 6.9% 3,466,521 0 3,466,521 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P. 0001879466
FHMLSP, L.L.C. 6.9% 3,466,521 0 3,466,521 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C. 0001879465
Frazier Life Sciences X, L.P. 2.3% 1,160,700 0 1,160,700 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P. 0001790879
FHMLS X, L.P. 2.3% 1,160,700 0 1,160,700 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P. 0001790880
FHMLS X, L.L.C. 2.3% 1,160,700 0 1,160,700 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C. 0001790811
Frazier Life Sciences XI, L.P. 0.8% 394,847 0 394,847 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P. 0001911592
FHMLS XI, L.P. 0.8% 394,847 0 394,847 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P. 0001911580
FHMLS XI, L.L.C. 0.8% 394,847 0 394,847 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C. 0001911623
James N. Topper 2.3% 1,160,700 0 1,160,700 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for James N. Topper, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017 0001341382
Patrick J. Heron 2.3% 1,160,700 0 1,160,700 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for Patrick J. Heron, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017 0001365617

Sponsored